Parapsoriasis and Pityriasis Lichenoides



Parapsoriasis: Introduction




| Print

Parapsoriasis at a Glance





  • Also known as parapsoriasis en plaques.
  • Parapsoriasis occurs worldwide and affects mainly adults.
  • Large-plaque parapsoriasis (LPP) and small-plaque parapsoriasis (SPP) are recognized.
  • Large and small “plaque” lesions actually present as flat patches rather than infiltrated plaques.
  • Lesions are chronic and favor nonsun-exposed skin; LPP may be poikilodermatous.
  • Pathology consists of superficial, mostly CD4+ T-cell infiltrate; dominant clonality is more common in LPP than in SPP.
  • LPP appears to exist on a continuum with patch-stage mycosis fungoides (MF) and progresses to overt MF at a rate of approximately 10% per decade.
  • SPP has minimal risk of progression to overt MF in the experience of most experts.
  • Treatment options include topical corticosteroids; ultraviolet B (UVB) irradiation, and psoralen and ultraviolet A (UVA) irradiation; excimer laser; and topical cytotoxic drugs.





Historical Aspects



The term parapsoriasis was coined originally by Brocq in 1902.1 As shown in Table 25-1, the currently accepted classification of parapsoriasis includes large- and small-plaque forms of parapsoriasis en plaques (often referred to simply as parapsoriasis) as well as acute and chronic forms of pityriasis lichenoides [known today as pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC), respectively].2 Pityriasis lichenoides was first described in 1894 by Neisser3 and Jadassohn.4 In 1899, Juliusberg delineated the chronic form and named it PLC.5 Mucha redescribed the acute form in 1916 and distinguished it from the chronic form.6 Habermann named the acute variant PLEVA in 1925.7 Mucha–Habermann disease is synonymous with PLEVA. Some authors regard lymphomatoid papulosis as a variant of pityriasis lichenoides, whereas others consider it to be a separate disease.2,810 Lymphomatoid papulosis is discussed in Chapter 145 as part of the spectrum of CD30+ cutaneous lymphoproliferative disorders.




Table 25-1 Classification of Parapsoriasis 






Epidemiology



Large-plaque parapsoriasis (LPP) and small-plaque parapsoriasis (SPP) are, in general, diseases of middle-aged and older people, with a peak incidence in the fifth decade. Occasionally, lesions arise in childhood and may be associated with pityriasis lichenoides. SPP shows a definite male predominance of approximately 3:1. LPP is probably more common in males, but the difference is not as striking as in SPP. Both occur in all racial groups and geographic regions.






Etiology and Pathogenesis



It is likely that a complete understanding of the pathogenesis of parapsoriasis will develop with our understanding of the pathogenesis of both chronic dermatitis and mycosis fungoides (MF), because parapsoriasis appears to bridge these disorders. The T cells that mediate most inflammatory skin diseases belong to the skin-associated lymphoid tissue (SALT).11 These T cells express the cutaneous lymphocyte-associated antigen and traffic between the skin and the T-cell domains of peripheral lymph nodes via the lymphatics and bloodstream. MF (see Chapter 145) has been shown to be a neoplasm of SALT T cells. Sensitive polymerase chain reaction (PCR)-based tumor clonality assays have underscored the SALT nature of MF tumor clones by showing that they can continue to traffic after neoplastic transformation12 and can even participate in delayed-type hypersensitivity reactions to contact allergens.13 This implies that rather than being a skin lymphoma per se, MF is actually a SALT lymphoma, i.e., a malignancy of a T-cell circuit rather than of one particular tissue. Trafficking of MF tumor cells has been detected even in patients with very early stage disease whose lesions were consistent clinicopathologically with LPP.12,14 Therefore, it can be said that at least in some cases LPP is a monoclonal proliferation of SALT T cells that have the capacity to traffic between the skin and extracutaneous sites.



This view is also supported by the presence of structural and numerical chromosomal abnormalities in the peripheral blood mononuclear cells of patients with LPP.15 In this context, LPP can be regarded as the clinically benign end of the MF disease spectrum, which eventuates in transformed large cell lymphoma at its malignant extreme. To say that these diseases belong to the same disease spectrum is not to say that they are biologically equivalent disorders. To lump them all together simply as “MF” would be to ignore their distinctive clinicopathologic features, which are likely due to genetic and/or epigenetic differences, such as the p53 gene somatic mutations observed in some cases of large cell transformation of MF.1618 It is likely that several such differences separate these clinicopathologically defined disorders in a stepwise fashion analogous to the sequential acquisition of somatic mutations that occurs in the colon cancer disease spectrum as colonic epithelial cells progress through normal, hyperplastic, in situ carcinoma, invasive carcinoma, and metastatic carcinoma stages.19,20



A unifying feature of the parapsoriasis group of diseases is that all of them appear to be cutaneous T-cell lymphoproliferative disorders: LPP,12,2128 SPP,23,28,29 pityriasis lichenoides,28,3032 and lymphomatoid papulosis23,3335 have all been shown to be monoclonal disorders in many cases.36 These relationships suggest that progression from LPP through the various stages of the MF disease spectrum is accompanied by an increasing gradient of dominant T-cell clonal density resulting from mutations that confer increasing growth autonomy to the neoplastic T-cell clone.37 Interestingly, analysis of peripheral blood has demonstrated that clonal T cells are often detectable in patients with LPP/early MF27,28 or SPP,28,38 which again supports the systemic SALT nature of these “primary” skin disorders.



Dominant clonality as seen in the parapsoriasis disease group, follicular mucinosis, pagetoid reticulosis, and certain other disorders does not equate to clinical malignancy. In fact, most patients with these diseases experience a benign clinical course, and in some cases the disease resolves completely. In addition, other types of chronic cutaneous T-cell infiltrates sometimes exhibit dominant clonality, including primary (idiopathic) erythroderma and nonspecific chronic spongiotic dermatitis. This has given rise to the concept of clonal dermatitis,14,39 originally described in the context of clonal nonspecific chronic spongiotic dermatitis but later expanded to include other nonlymphomatous cutaneous T-cell infiltrates that harbor occult monoclonal T-cell populations. Several cases of clonal dermatitis, some of which have progressed to MF, have been identified.14,21,39 We suspect that for each disease with a potential for progression to MF, the principal risk may reside in the subset showing clonal dermatitis, because this is the subset in which dysregulation has begun to occur.



The postulated relationships among MF, clonal dermatitis, and selected types of chronic dermatitis are depicted in Fig. 25-1. Each of the entities shown is postulated to be at risk for MF through a clonal dermatitis intermediate. In this model, MF becomes the final common pathway for the clonal evolution of neoplastic T cells emerging from the polyclonal SALT T-cell populations present in each of the various precursor diseases.




Figure 25-1



The relationship of clonal dermatitis to mycosis fungoides (MF) and various types of chronic dermatitis. The proportions of each entity that represent clonal dermatitis and mycosis fungoides vary with each disease and are not drawn to scale. FM = follicular mucinosis; LPP = large-plaque parapsoriasis; NCSD = nonspecific chronic spongiotic dermatitis; PE = primary erythroderma.




Various viruses have been proposed to play a role in the pathogenesis of MF. None has been substantiated thus far. The most recent virus implicated in both LPP and MF is HHV-8; however, conflicting reports await resolution.4042






Clinical Findings



Cutaneous Lesions



LPP lesions are either oval or irregularly shaped patches or very thin plaques that are asymptomatic or mildly pruritic. They are usually well marginated but may also blend imperceptibly into the surrounding skin. The size is variable, but typically most lesions are larger than 5 cm, often measuring more than 10 cm in diameter. Lesions are stable in size and may increase in number gradually. They are found mainly on the “bathing trunk” and flexural areas (Fig. 25-2). Extremities and the upper trunk, especially the breasts in women, also may be involved. They are light red–brown or salmon pink, and their surface is covered with small and scanty scales. Lesions may appear finely wrinkled—“cigarette paper” wrinkling. Such lesions exhibit varying degrees of epidermal atrophy. Telangiectasia and mottled pigmentation also are observed when the atrophy becomes prominent (Fig. 25-3). This triad of atrophy, mottled pigmentation, and telangiectasia defines the term poikiloderma or poikiloderma atrophicans vasculare, which also may be seen in other conditions (Box 25-1).




Figure 25-2



Large-plaque parapsoriasis. Irregularly shaped patches of variable size on the arm of a 16-year-old girl.





Figure 25-3



Large-plaque parapsoriasis. Poikilodermatous variant.




Retiform parapsoriasis refers to a rare variant of LPP that presents as an extensive eruption of scaly macules and papules in a net-like or zebra-stripe pattern that eventually becomes poikilodermatous (Fig. 25-4).




Figure 25-4



Large-plaque parapsoriasis. Retiform variant.




SPP characteristically occurs as round or oval discrete patches or very thin plaques, mainly on the trunk (Fig. 25-5). The lesions measure less than 5 cm in diameter; they are asymptomatic and covered with fine, moderately adherent scales. The general health of the patient is unaffected. A distinctive variant with lesions of a finger shape, known as digitate dermatosis,43 has yellowish or fawn-colored lesions (Fig. 25-6). It follows lines of cleavage of the skin and gives the appearance of a hug that left fingerprints on the trunk. The long axis of these lesions often measures greater than 5 cm. Chronic superficial dermatitis is a synonym for SPP.44 Digitate lesions with a yellow hue were referred to in the past as xanthoerythrodermia perstans.2




Figure 25-5



Small-plaque parapsoriasis. Small, discrete patches less than 5 cm in diameter.





Figure 25-6



Small-plaque parapsoriasis. Digitate dermatosis variant. Typical “fingerprint” patches on the flank. Note that their length often exceeds 5 cm.





Box 25-1 Differential Diagnosis of Poikiloderma 






Laboratory Tests



Histopathology



In early LPP lesions, the epidermis is mildly acanthotic and slightly hyperkeratotic with spotty parakeratosis. The dermal lymphocytic infiltrate tends to be perivascular and scattered (Fig. 25-7). In the more advanced lesions one observes an interface infiltrate with definite epidermotropism. These invading lymphocytes may be scattered singly or in groups, sometimes associated with mild spongiosis. In addition, the poikilodermatous lesions show atrophic epidermis, dilated blood vessels, and melanophages (Fig. 25-8). Immunohistologic studies have revealed similar features in LPP and early MF, including a predominance of CD4+ T-cell subsets, frequent CD7 antigen deficiency, and widespread epidermal expression of Class II HLA (HLA-DR).2224,4548




Figure 25-7



Large-plaque parapsoriasis. Mildly hyperkeratotic and focally parakeratotic epidermis with moderately dense superficial perivascular infiltrate. Lymphoid cells are mostly small, cytologically normal lymphocytes, and there is focal single-cell epidermotropism. (Used with permission from Helmut Kerl, MD.)





Figure 25-8



Large-plaque parapsoriasis. Atrophic variant. Sparse superficial lymphoid infiltrate with mild epidermotropism and epidermal atrophy.




SPP exhibits mild spongiotic dermatitis with focal areas of hyperkeratosis, parakeratosis, scale crust, and exocytosis. In the dermis, there is a mild superficial perivascular lymphohistiocytic infiltrate and dermal edema (Fig. 25-9). There is no progression of the histologic features with time. Immunohistologic studies reveal a predominantly CD4+ T-cell infiltrate with nonspecific features resembling those seen in various types of dermatitides.47




Figure 25-9



Small-plaque parapsoriasis. Superficial perivascular lymphoid infiltrate, mild spongiosis, parakeratosis, and focal scale crust.







Diagnosis and Differential Diagnosis



LPP is distinguished from SPP by the larger size, asymmetric distribution, and irregular shape of its lesions, which are less discrete and often poikilodermatous. LPP may be clinically and histopathologically indistinguishable from the patch stage of MF. Both LPP and SPP are readily distinguished from more advanced infiltrated plaques of MF because parapsoriasis lesions are, by definition, not thicker than patches or at most very thin plaques. This is so because the English equivalent of the French term plaques is patches, i.e., lesions that are essentially flat and devoid of induration or palpable infiltration.49 Failure to appreciate this important distinction has led to considerable confusion and misuse of the terms large-plaque parapsoriasis and small-plaque parapsoriasis by some individuals. These designations more appropriately might be thought of as large-patch parapsoriasis and small-patch parapsoriasis.



The degree to which LPP is differentiated from early MF depends primarily on the histopathologic criteria used to diagnose the latter disorder. Unfortunately, there are no universally accepted minimal criteria for the diagnosis of MF; however, one set proposed by the International Society for Cutaneous Lymphoma is presented in Table 25-2.50 This algorithm is based on a holistic integration of clinical, histopathologic, immunopathologic, and clonality data. It differs significantly from many prior approaches because it does not rely solely on histopathologic features.51 Assuming that histopathologic examination does not disclose features diagnostic of some other dermatosis, these criteria allow lesions to be classified as either patch-stage MF or not. For the practical purposes of clinical management, patients presenting clinically with patch lesions whose features result in a score of four points or more are considered to have unequivocal MF. Obviously, the more liberal the criteria, the more cases could be considered to be MF. However, there will always be some cases that fail to meet any specific set of criteria, and the designation LPP is a useful term to apply to them because it guides treatment and follow-up and conveys an understanding that the risk of dying from lymphoma is small.




Table 25-2 Algorithm for the Diagnosis of Patch-Stage Mycosis Fungoides (Four Points Are Required) 



The clinical and/or histopathologic differential diagnosis of LPP also includes those collagen vascular diseases and genodermatoses exhibiting poikilodermatous features, lichenoid drug eruptions, secondary syphilis, chronic radiodermatitis, and occasionally several other diseases tabulated in Box 25-2. These generally can be distinguished by their associated clinical findings. Histopathologic differentiation among these diseases is covered largely in the discussion of pseudo-MF in Chapter 146.




Box 25-2 Differential Diagnosis of Large-Plaque Parapsoriasis (LPP) and Small-Plaque Parapsoriasis (SPP) 



SPP, when it presents with its distinctive digitate dermatosis lesions parallel to skin lines in a truncal distribution, stands out from other types of parapsoriasis. Individual SPP lesions may show some superficial resemblance to PLC. SPP is distinguished from psoriasis by the absence of the Auspitz sign (see Chapter 18), micaceous scale, nail pits, and typical psoriatic lesions involving the scalp, elbows, and knees. Histologically, its mild spongiotic dermatitis and absence of other characteristic features distinguish it from PLC, psoriasis, and several of the other entities listed in Box 25-2. Clinical features are also important, such as the herald patch of pityriasis rosea and the papulovesicular coin-shaped patches favoring the lower extremities in nummular dermatitis.



Sometimes patients with MF may exhibit small patches of disease at presentation; however, these lesions typically have histopathologic features at least consistent with MF and generally are associated with larger, more classic lesions of MF elsewhere on the skin. They also may show poikilodermatous features not seen in SPP. Furthermore, the presence of well-developed, moderate to thick small plaques, as seen in some MF patients, is incompatible with the diagnosis of SPP because the latter disorder includes only lesions that are no more than patches or very thin plaques. It is also important to recognize that partially treated or early relapsing lesions of MF may show only nonspecific features that should not be taken as evidence of a pathogenetic link to SPP or any other dermatosis.






Complications



LPP can be associated with other forms of parapsoriasis and overt cutaneous lymphomas as detailed elsewhere in this chapter. Both LPP and SPP occasionally can develop areas of impetiginization secondary to excoriation.






Prognosis and Clinical Course



Both LPP and SPP may persist for years to decades with little change in appearance clinically or histopathologically. Approximately 10%–30% of cases of LPP progress to overt MF.2,5254 In this context, LPP represents the clinically benign end of the MF disease spectrum, with transformation to large cell lymphoma at the opposite extreme. The rare retiform variant is said to progress to overt MF in virtually all cases.2



In contrast to LPP with its malignant potential, SPP is a clinically benign disorder in the experience of most experts. Patients with this disease as defined in this chapter rarely develop overt MF.11,44,55,56 Despite this fact and what most observers consider to be its nonspecific histopathologic features, some authors favor lumping SPP within the MF disease spectrum as a very early, nonprogressive variant.55,57 This issue has been debated at length.31,57,58 A few studies report progression from SPP to MF in about 10% of cases but may have used different criteria than described in this chapter.53,54

Only gold members can continue reading. Log In or Register to continue

Jun 11, 2016 | Posted by in Dermatology | Comments Off on Parapsoriasis and Pityriasis Lichenoides
Premium Wordpress Themes by UFO Themes